866-997-4948(US-Canada Toll Free)

United States Flu Vaccine (Influenza Vaccine) Market Report 2018

Published By :

QYResearch

Published Date : Jul 2018

Category :

Pharmaceutical

No. of Pages : 102 Pages

In this report, the United States Flu Vaccine (Influenza Vaccine) market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Flu Vaccine (Influenza Vaccine) in these regions, from 2013 to 2025 (forecast).

United States Flu Vaccine (Influenza Vaccine) market competition by top manufacturers/players, with Flu Vaccine (Influenza Vaccine) sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
CSL
GSK
Sanofi Pasteur
Mylan
AstraZeneca
Pfizer
Johnson & Johnson
...

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Whole Virus Vaccines
Split Virus Vaccines
Subunit Vaccines
Live Attenuated Virus Vaccines
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
For Children (6 months to 3 years)
For Adults and Children over 3 years

Table of Contents

United States Flu Vaccine (Influenza Vaccine) Market Report 2018
1 Flu Vaccine (Influenza Vaccine) Overview
1.1 Product Overview and Scope of Flu Vaccine (Influenza Vaccine)
1.2 Classification of Flu Vaccine (Influenza Vaccine) by Product Category
1.2.1 United States Flu Vaccine (Influenza Vaccine) Market Size (Sales Volume) Comparison by Type (2013-2025)
1.2.2 United States Flu Vaccine (Influenza Vaccine) Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
1.2.3 Whole Virus Vaccines
1.2.4 Split Virus Vaccines
1.2.5 Subunit Vaccines
1.2.6 Live Attenuated Virus Vaccines
1.3 United States Flu Vaccine (Influenza Vaccine) Market by Application/End Users
1.3.1 United States Flu Vaccine (Influenza Vaccine) Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
1.3.2 For Children (6 months to 3 years)
1.3.3 For Adults and Children over 3 years
1.4 United States Flu Vaccine (Influenza Vaccine) Market by Region
1.4.1 United States Flu Vaccine (Influenza Vaccine) Market Size (Value) Comparison by Region (2013-2025)
1.4.2 The West Flu Vaccine (Influenza Vaccine) Status and Prospect (2013-2025)
1.4.3 Southwest Flu Vaccine (Influenza Vaccine) Status and Prospect (2013-2025)
1.4.4 The Middle Atlantic Flu Vaccine (Influenza Vaccine) Status and Prospect (2013-2025)
1.4.5 New England Flu Vaccine (Influenza Vaccine) Status and Prospect (2013-2025)
1.4.6 The South Flu Vaccine (Influenza Vaccine) Status and Prospect (2013-2025)
1.4.7 The Midwest Flu Vaccine (Influenza Vaccine) Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Flu Vaccine (Influenza Vaccine) (2013-2025)
1.5.1 United States Flu Vaccine (Influenza Vaccine) Sales and Growth Rate (2013-2025)
1.5.2 United States Flu Vaccine (Influenza Vaccine) Revenue and Growth Rate (2013-2025)

2 United States Flu Vaccine (Influenza Vaccine) Market Competition by Players/Suppliers
2.1 United States Flu Vaccine (Influenza Vaccine) Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Flu Vaccine (Influenza Vaccine) Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Flu Vaccine (Influenza Vaccine) Average Price by Players/Suppliers (2013-2018)
2.4 United States Flu Vaccine (Influenza Vaccine) Market Competitive Situation and Trends
2.4.1 United States Flu Vaccine (Influenza Vaccine) Market Concentration Rate
2.4.2 United States Flu Vaccine (Influenza Vaccine) Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Flu Vaccine (Influenza Vaccine) Manufacturing Base Distribution, Sales Area, Product Type

3 United States Flu Vaccine (Influenza Vaccine) Sales (Volume) and Revenue (Value) by Region (2013-2018)
3.1 United States Flu Vaccine (Influenza Vaccine) Sales and Market Share by Region (2013-2018)
3.2 United States Flu Vaccine (Influenza Vaccine) Revenue and Market Share by Region (2013-2018)
3.3 United States Flu Vaccine (Influenza Vaccine) Price by Region (2013-2018)

4 United States Flu Vaccine (Influenza Vaccine) Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018)
4.1 United States Flu Vaccine (Influenza Vaccine) Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Flu Vaccine (Influenza Vaccine) Revenue and Market Share by Type (2013-2018)
4.3 United States Flu Vaccine (Influenza Vaccine) Price by Type (2013-2018)
4.4 United States Flu Vaccine (Influenza Vaccine) Sales Growth Rate by Type (2013-2018)

5 United States Flu Vaccine (Influenza Vaccine) Sales (Volume) by Application (2013-2018)
5.1 United States Flu Vaccine (Influenza Vaccine) Sales and Market Share by Application (2013-2018)
5.2 United States Flu Vaccine (Influenza Vaccine) Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 United States Flu Vaccine (Influenza Vaccine) Players/Suppliers Profiles and Sales Data
6.1 CSL
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Flu Vaccine (Influenza Vaccine) Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 CSL Flu Vaccine (Influenza Vaccine) Sales, Revenue, Price and Gross Margin (2013-2018)
6.1.4 Main Business/Business Overview
6.2 GSK
6.2.2 Flu Vaccine (Influenza Vaccine) Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 GSK Flu Vaccine (Influenza Vaccine) Sales, Revenue, Price and Gross Margin (2013-2018)
6.2.4 Main Business/Business Overview
6.3 Sanofi Pasteur
6.3.2 Flu Vaccine (Influenza Vaccine) Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Sanofi Pasteur Flu Vaccine (Influenza Vaccine) Sales, Revenue, Price and Gross Margin (2013-2018)
6.3.4 Main Business/Business Overview
6.4 Mylan
6.4.2 Flu Vaccine (Influenza Vaccine) Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Mylan Flu Vaccine (Influenza Vaccine) Sales, Revenue, Price and Gross Margin (2013-2018)
6.4.4 Main Business/Business Overview
6.5 AstraZeneca
6.5.2 Flu Vaccine (Influenza Vaccine) Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 AstraZeneca Flu Vaccine (Influenza Vaccine) Sales, Revenue, Price and Gross Margin (2013-2018)
6.5.4 Main Business/Business Overview
6.6 Pfizer
6.6.2 Flu Vaccine (Influenza Vaccine) Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Pfizer Flu Vaccine (Influenza Vaccine) Sales, Revenue, Price and Gross Margin (2013-2018)
6.6.4 Main Business/Business Overview
6.7 Johnson & Johnson
6.7.2 Flu Vaccine (Influenza Vaccine) Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Johnson & Johnson Flu Vaccine (Influenza Vaccine) Sales, Revenue, Price and Gross Margin (2013-2018)
6.7.4 Main Business/Business Overview
...

7 Flu Vaccine (Influenza Vaccine) Manufacturing Cost Analysis
7.1 Flu Vaccine (Influenza Vaccine) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Flu Vaccine (Influenza Vaccine)

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Flu Vaccine (Influenza Vaccine) Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Flu Vaccine (Influenza Vaccine) Major Manufacturers in 2017
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Flu Vaccine (Influenza Vaccine) Market Size (Value and Volume) Forecast (2018-2025)
11.1 United States Flu Vaccine (Influenza Vaccine) Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Flu Vaccine (Influenza Vaccine) Sales Volume Forecast by Type (2018-2025)
11.3 United States Flu Vaccine (Influenza Vaccine) Sales Volume Forecast by Application (2018-2025)
11.4 United States Flu Vaccine (Influenza Vaccine) Sales Volume Forecast by Region (2018-2025)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer

List of Table

List of Tables and Figures

Figure Product Picture of Flu Vaccine (Influenza Vaccine)
Figure United States Flu Vaccine (Influenza Vaccine) Market Size (K Doses) by Type (2013-2025)
Figure United States Flu Vaccine (Influenza Vaccine) Sales Volume Market Share by Type (Product Category) in 2017
Figure Whole Virus Vaccines Product Picture
Figure Split Virus Vaccines Product Picture
Figure Subunit Vaccines Product Picture
Figure Live Attenuated Virus Vaccines Product Picture
Figure United States Flu Vaccine (Influenza Vaccine) Market Size (K Doses) by Application (2013-2025)
Figure United States Sales Market Share of Flu Vaccine (Influenza Vaccine) by Application in 2017
Figure For Children (6 months to 3 years) Examples
Table Key Downstream Customer in For Children (6 months to 3 years)
Figure For Adults and Children over 3 years Examples
Table Key Downstream Customer in For Adults and Children over 3 years
Figure United States Flu Vaccine (Influenza Vaccine) Market Size (Million USD) by Region (2013-2025)
Figure The West Flu Vaccine (Influenza Vaccine) Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Flu Vaccine (Influenza Vaccine) Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Flu Vaccine (Influenza Vaccine) Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Flu Vaccine (Influenza Vaccine) Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Flu Vaccine (Influenza Vaccine) Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Flu Vaccine (Influenza Vaccine) Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Flu Vaccine (Influenza Vaccine) Sales (K Doses) and Growth Rate (2013-2025)
Figure United States Flu Vaccine (Influenza Vaccine) Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Flu Vaccine (Influenza Vaccine) Market Major Players Product Sales Volume (K Doses) (2013-2018)
Table United States Flu Vaccine (Influenza Vaccine) Sales (K Doses) of Key Players/Suppliers (2013-2018)
Table United States Flu Vaccine (Influenza Vaccine) Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Flu Vaccine (Influenza Vaccine) Sales Share by Players/Suppliers
Figure 2017 United States Flu Vaccine (Influenza Vaccine) Sales Share by Players/Suppliers
Figure United States Flu Vaccine (Influenza Vaccine) Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Flu Vaccine (Influenza Vaccine) Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Flu Vaccine (Influenza Vaccine) Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Flu Vaccine (Influenza Vaccine) Revenue Share by Players/Suppliers
Figure 2017 United States Flu Vaccine (Influenza Vaccine) Revenue Share by Players/Suppliers
Table United States Market Flu Vaccine (Influenza Vaccine) Average Price (USD/Doses) of Key Players/Suppliers (2013-2018)
Figure United States Market Flu Vaccine (Influenza Vaccine) Average Price (USD/Doses) of Key Players/Suppliers in 2017
Figure United States Flu Vaccine (Influenza Vaccine) Market Share of Top 3 Players/Suppliers
Figure United States Flu Vaccine (Influenza Vaccine) Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Flu Vaccine (Influenza Vaccine) Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Flu Vaccine (Influenza Vaccine) Product Category
Table United States Flu Vaccine (Influenza Vaccine) Sales (K Doses) by Region (2013-2018)
Table United States Flu Vaccine (Influenza Vaccine) Sales Share by Region (2013-2018)
Figure United States Flu Vaccine (Influenza Vaccine) Sales Share by Region (2013-2018)
Figure United States Flu Vaccine (Influenza Vaccine) Sales Market Share by Region in 2017
Table United States Flu Vaccine (Influenza Vaccine) Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Flu Vaccine (Influenza Vaccine) Revenue Share by Region (2013-2018)
Figure United States Flu Vaccine (Influenza Vaccine) Revenue Market Share by Region (2013-2018)
Figure United States Flu Vaccine (Influenza Vaccine) Revenue Market Share by Region in 2017
Table United States Flu Vaccine (Influenza Vaccine) Price (USD/Doses) by Region (2013-2018)
Table United States Flu Vaccine (Influenza Vaccine) Sales (K Doses) by Type (2013-2018)
Table United States Flu Vaccine (Influenza Vaccine) Sales Share by Type (2013-2018)
Figure United States Flu Vaccine (Influenza Vaccine) Sales Share by Type (2013-2018)
Figure United States Flu Vaccine (Influenza Vaccine) Sales Market Share by Type in 2017
Table United States Flu Vaccine (Influenza Vaccine) Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Flu Vaccine (Influenza Vaccine) Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Flu Vaccine (Influenza Vaccine) by Type (2013-2018)
Figure Revenue Market Share of Flu Vaccine (Influenza Vaccine) by Type in 2017
Table United States Flu Vaccine (Influenza Vaccine) Price (USD/Doses) by Types (2013-2018)
Figure United States Flu Vaccine (Influenza Vaccine) Sales Growth Rate by Type (2013-2018)
Table United States Flu Vaccine (Influenza Vaccine) Sales (K Doses) by Application (2013-2018)
Table United States Flu Vaccine (Influenza Vaccine) Sales Market Share by Application (2013-2018)
Figure United States Flu Vaccine (Influenza Vaccine) Sales Market Share by Application (2013-2018)
Figure United States Flu Vaccine (Influenza Vaccine) Sales Market Share by Application in 2017
Table United States Flu Vaccine (Influenza Vaccine) Sales Growth Rate by Application (2013-2018)
Figure United States Flu Vaccine (Influenza Vaccine) Sales Growth Rate by Application (2013-2018)
Table CSL Basic Information List
Table CSL Flu Vaccine (Influenza Vaccine) Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2013-2018)
Figure CSL Flu Vaccine (Influenza Vaccine) Sales Growth Rate (2013-2018)
Figure CSL Flu Vaccine (Influenza Vaccine) Sales Market Share in United States (2013-2018)
Figure CSL Flu Vaccine (Influenza Vaccine) Revenue Market Share in United States (2013-2018)
Table GSK Basic Information List
Table GSK Flu Vaccine (Influenza Vaccine) Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2013-2018)
Figure GSK Flu Vaccine (Influenza Vaccine) Sales Growth Rate (2013-2018)
Figure GSK Flu Vaccine (Influenza Vaccine) Sales Market Share in United States (2013-2018)
Figure GSK Flu Vaccine (Influenza Vaccine) Revenue Market Share in United States (2013-2018)
Table Sanofi Pasteur Basic Information List
Table Sanofi Pasteur Flu Vaccine (Influenza Vaccine) Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2013-2018)
Figure Sanofi Pasteur Flu Vaccine (Influenza Vaccine) Sales Growth Rate (2013-2018)
Figure Sanofi Pasteur Flu Vaccine (Influenza Vaccine) Sales Market Share in United States (2013-2018)
Figure Sanofi Pasteur Flu Vaccine (Influenza Vaccine) Revenue Market Share in United States (2013-2018)
Table Mylan Basic Information List
Table Mylan Flu Vaccine (Influenza Vaccine) Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2013-2018)
Figure Mylan Flu Vaccine (Influenza Vaccine) Sales Growth Rate (2013-2018)
Figure Mylan Flu Vaccine (Influenza Vaccine) Sales Market Share in United States (2013-2018)
Figure Mylan Flu Vaccine (Influenza Vaccine) Revenue Market Share in United States (2013-2018)
Table AstraZeneca Basic Information List
Table AstraZeneca Flu Vaccine (Influenza Vaccine) Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2013-2018)
Figure AstraZeneca Flu Vaccine (Influenza Vaccine) Sales Growth Rate (2013-2018)
Figure AstraZeneca Flu Vaccine (Influenza Vaccine) Sales Market Share in United States (2013-2018)
Figure AstraZeneca Flu Vaccine (Influenza Vaccine) Revenue Market Share in United States (2013-2018)
Table Pfizer Basic Information List
Table Pfizer Flu Vaccine (Influenza Vaccine) Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2013-2018)
Figure Pfizer Flu Vaccine (Influenza Vaccine) Sales Growth Rate (2013-2018)
Figure Pfizer Flu Vaccine (Influenza Vaccine) Sales Market Share in United States (2013-2018)
Figure Pfizer Flu Vaccine (Influenza Vaccine) Revenue Market Share in United States (2013-2018)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Flu Vaccine (Influenza Vaccine) Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2013-2018)
Figure Johnson & Johnson Flu Vaccine (Influenza Vaccine) Sales Growth Rate (2013-2018)
Figure Johnson & Johnson Flu Vaccine (Influenza Vaccine) Sales Market Share in United States (2013-2018)
Figure Johnson & Johnson Flu Vaccine (Influenza Vaccine) Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Flu Vaccine (Influenza Vaccine)
Figure Manufacturing Process Analysis of Flu Vaccine (Influenza Vaccine)
Figure Flu Vaccine (Influenza Vaccine) Industrial Chain Analysis
Table Raw Materials Sources of Flu Vaccine (Influenza Vaccine) Major Players/Suppliers in 2017
Table Major Buyers of Flu Vaccine (Influenza Vaccine)
Table Distributors/Traders List
Figure United States Flu Vaccine (Influenza Vaccine) Sales Volume (K Doses) and Growth Rate Forecast (2018-2025)
Figure United States Flu Vaccine (Influenza Vaccine) Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Flu Vaccine (Influenza Vaccine) Price (USD/Doses) Trend Forecast (2018-2025)
Table United States Flu Vaccine (Influenza Vaccine) Sales Volume (K Doses) Forecast by Type (2018-2025)
Figure United States Flu Vaccine (Influenza Vaccine) Sales Volume (K Doses) Forecast by Type (2018-2025)
Figure United States Flu Vaccine (Influenza Vaccine) Sales Volume (K Doses) Forecast by Type in 2025
Table United States Flu Vaccine (Influenza Vaccine) Sales Volume (K Doses) Forecast by Application (2018-2025)
Figure United States Flu Vaccine (Influenza Vaccine) Sales Volume (K Doses) Forecast by Application (2018-2025)
Figure United States Flu Vaccine (Influenza Vaccine) Sales Volume (K Doses) Forecast by Application in 2025
Table United States Flu Vaccine (Influenza Vaccine) Sales Volume (K Doses) Forecast by Region (2018-2025)
Table United States Flu Vaccine (Influenza Vaccine) Sales Volume Share Forecast by Region (2018-2025)
Figure United States Flu Vaccine (Influenza Vaccine) Sales Volume Share Forecast by Region (2018-2025)
Figure United States Flu Vaccine (Influenza Vaccine) Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *